Cargando…

Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014

OBJECTIVES: To verify whether a simplified method based on age, body mass index (BMI) and glycated haemoglobin (HbA1c) is feasible in classifying patients with type 2 diabetes (T2D), and evaluate the predictive ability of subgroups in several health and mortality outcomes. DESIGN: Retrospective coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jing, Shao, Hua, Shan, Tao, Jing, Shenqi, Shi, Yaxiang, Wang, Junjie, Hu, Jie, Li, Yong, Huang, Ruochen, Liu, Naifeng, Liu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969050/
https://www.ncbi.nlm.nih.gov/pubmed/35354619
http://dx.doi.org/10.1136/bmjopen-2021-055647
_version_ 1784679177909174272
author Xie, Jing
Shao, Hua
Shan, Tao
Jing, Shenqi
Shi, Yaxiang
Wang, Junjie
Hu, Jie
Li, Yong
Huang, Ruochen
Liu, Naifeng
Liu, Yun
author_facet Xie, Jing
Shao, Hua
Shan, Tao
Jing, Shenqi
Shi, Yaxiang
Wang, Junjie
Hu, Jie
Li, Yong
Huang, Ruochen
Liu, Naifeng
Liu, Yun
author_sort Xie, Jing
collection PubMed
description OBJECTIVES: To verify whether a simplified method based on age, body mass index (BMI) and glycated haemoglobin (HbA1c) is feasible in classifying patients with type 2 diabetes (T2D), and evaluate the predictive ability of subgroups in several health and mortality outcomes. DESIGN: Retrospective cohort study. SETTING: The National Health and Nutrition Examination Survey 1999–2014 cycle. PARTICIPANTS: A total of 1960 participants with diabetes and the age at diagnosis greater than 30. PRIMARY AND SECONDARY OUTCOME MEASURES: Participants with T2D were assigned to previously defined (by Ahlqvist) subgroups based on five variables: age, BMI, HbA1c, homoeostasis model assessment (HOMA) 2 estimates of β-cell function (HOMA2-B), and insulin resistance (HOMA2-IR), and on three variables: age, BMI and HbA1c. The classification performances of the three variables were evaluated based on 10-fold cross validation, with accuracy, precision and recall as evaluation criteria. Outcomes were assessed using logistic regression and Cox regression analysis. RESULTS: Without HOMA measurements, it is difficult to identify severe insulin-resistant diabetes, but other subgroups can be ideally identified. There is no significant difference between the five variables and the three variables in the ability to predict the prevalence of poor cardiovascular health (CVH), chronic kidney disease, non-alcoholic fatty liver disease and advanced liver fibrosis, and the risk of all-cause, cardiovascular disease and cancer-related mortality (p>0.05), except the prevalence of poor CVH in mild age-related diabetes (p<0.05). CONCLUSIONS: A simple classification based on age, BMI and HbA1c could be used to identify T2D with several health and mortality risks, which is accessible in most individuals with T2D. Due to its simplicity and practicality, more patients with T2D can benefit from subgroup specific treatment paradigms.
format Online
Article
Text
id pubmed-8969050
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89690502022-04-20 Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014 Xie, Jing Shao, Hua Shan, Tao Jing, Shenqi Shi, Yaxiang Wang, Junjie Hu, Jie Li, Yong Huang, Ruochen Liu, Naifeng Liu, Yun BMJ Open Diabetes and Endocrinology OBJECTIVES: To verify whether a simplified method based on age, body mass index (BMI) and glycated haemoglobin (HbA1c) is feasible in classifying patients with type 2 diabetes (T2D), and evaluate the predictive ability of subgroups in several health and mortality outcomes. DESIGN: Retrospective cohort study. SETTING: The National Health and Nutrition Examination Survey 1999–2014 cycle. PARTICIPANTS: A total of 1960 participants with diabetes and the age at diagnosis greater than 30. PRIMARY AND SECONDARY OUTCOME MEASURES: Participants with T2D were assigned to previously defined (by Ahlqvist) subgroups based on five variables: age, BMI, HbA1c, homoeostasis model assessment (HOMA) 2 estimates of β-cell function (HOMA2-B), and insulin resistance (HOMA2-IR), and on three variables: age, BMI and HbA1c. The classification performances of the three variables were evaluated based on 10-fold cross validation, with accuracy, precision and recall as evaluation criteria. Outcomes were assessed using logistic regression and Cox regression analysis. RESULTS: Without HOMA measurements, it is difficult to identify severe insulin-resistant diabetes, but other subgroups can be ideally identified. There is no significant difference between the five variables and the three variables in the ability to predict the prevalence of poor cardiovascular health (CVH), chronic kidney disease, non-alcoholic fatty liver disease and advanced liver fibrosis, and the risk of all-cause, cardiovascular disease and cancer-related mortality (p>0.05), except the prevalence of poor CVH in mild age-related diabetes (p<0.05). CONCLUSIONS: A simple classification based on age, BMI and HbA1c could be used to identify T2D with several health and mortality risks, which is accessible in most individuals with T2D. Due to its simplicity and practicality, more patients with T2D can benefit from subgroup specific treatment paradigms. BMJ Publishing Group 2022-03-29 /pmc/articles/PMC8969050/ /pubmed/35354619 http://dx.doi.org/10.1136/bmjopen-2021-055647 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Diabetes and Endocrinology
Xie, Jing
Shao, Hua
Shan, Tao
Jing, Shenqi
Shi, Yaxiang
Wang, Junjie
Hu, Jie
Li, Yong
Huang, Ruochen
Liu, Naifeng
Liu, Yun
Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014
title Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014
title_full Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014
title_fullStr Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014
title_full_unstemmed Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014
title_short Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014
title_sort validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of nhanes data from 1999 to 2014
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969050/
https://www.ncbi.nlm.nih.gov/pubmed/35354619
http://dx.doi.org/10.1136/bmjopen-2021-055647
work_keys_str_mv AT xiejing validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT shaohua validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT shantao validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT jingshenqi validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT shiyaxiang validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT wangjunjie validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT hujie validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT liyong validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT huangruochen validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT liunaifeng validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014
AT liuyun validationoftype2diabetessubgroupsbysimpleclinicalparametersaretrospectivecohortstudyofnhanesdatafrom1999to2014